AF screening for people with heart changes on echo
Part of Heart & circulation clinical trials.
This trial checks if people with certain heart conditions seen on an echo (like an enlarged heart or stiff heart muscle) have undetected atrial fibrillation (AF). It aims to find AF early so it can be treated to prevent strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one of these heart conditions on an echo: enlarged left atrium (LAE), thickened heart muscle (LVH), or a stiff heart muscle (E/e' > 14).
- You have moderate or severe diastolic dysfunction (grade II or III).
- You have heart valve disease (VHD).
- You have heart failure with a weak pumping heart (LVEF < 40%) or heart failure with preserved pumping heart (LVEF ≥ 40%) plus symptoms and a high NT-proBNP level.
- You have never been diagnosed with atrial fibrillation or atrial flutter.
- You do not have congenital heart disease, recent heart attack (within 3 months), uncontrolled overactive thyroid, end-stage kidney disease, unstable blood pressure, or a life expectancy less than 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special heart tests (AI-ECG and CT scan) to look for a hidden condition called cardiac amyloidosis, which can affect people with atrial fibrillation. Finding it early may help guide treatment and improve outcomes.
This trial uses an artificial intelligence tool to read your heart's electrical signals and check how well your heart is recovering after a procedure to fix an irregular heartbeat called atrial fibrillation. It aims to find early signs of heart failure and guide better care.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This trial tests whether a procedure called electrical cardioversion (a controlled shock to reset your heart rhythm) can help explain and possibly improve symptoms of atrial fibrillation and heart failure. If you qualify, you'll receive this procedure and your symptoms will be closely monitored.
This study uses an artificial intelligence (AI) tool to read your heart's electrical activity (ECG) to help doctors better manage your atrial fibrillation (AFib), an irregular heartbeat that can increase stroke risk. By combining the ECG with a heart ultrasound (echocardiogram), the AI aims to improve treatment decisions and outcomes.
This study tests a new way to use ultrasound (echocardiogram) to measure heart pressure in people who have both heart failure and atrial fibrillation (irregular heartbeat). Participants will have an ultrasound and a heart catheterization to see if the new ultrasound method can accurately detect elevated pressures.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.